Show simple item record

dc.contributor.authorAkbari, F
dc.contributor.authorEskandani, M
dc.contributor.authorKhosroushahi, AY
dc.date.accessioned2018-08-26T06:04:34Z
dc.date.available2018-08-26T06:04:34Z
dc.date.issued2014
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/41498
dc.description.abstractMicroalgae have been used in food, cosmetic, and biofuel industries as a natural source of lipids, vitamins, pigments and antioxidants for a long time. Green microalgae, as potent photobioreactors, can be considered as an economical expression system to produce recombinant therapeutical proteins at large-scale due to low cost of production and scaling-up capitalization owning to the inexpensive medium requirement, fast growth rate, and the ease of manipulation. These microalgae possess all benefit eukaryotic expression systems including the ability of post-translational modifications required for proper folding and stability of active proteins. Among the many items regarded as recombinant protein production, this review compares the different expression systems with green microalgae like Dunaliella by viewing the nuclear/chloroplast transformation challenges/benefits, related selection markers/reporter genes, and crucial factors/strategies affecting the increase of foreign protein expression in microalgae transformants. Some important factors were discussed regarding the increase of protein yielding in microalgae transformants including: transformation-associated genotypic modifications, endogenous regulatory factors, promoters, codon optimization, enhancer elements, and milking of recombinant protein.
dc.language.isoEnglish
dc.relation.ispartofWorld journal of microbiology & biotechnology
dc.subjectBiological Products
dc.subjectBiotechnology
dc.subjectChlorophyta
dc.subjectMicroalgae
dc.subjectOrganisms, Genetically Modified
dc.subjectPhotobioreactors
dc.subjectRecombinant Proteins
dc.subjectTechnology, Pharmaceutical
dc.titleThe potential of transgenic green microalgae; a robust photobioreactor to produce recombinant therapeutic proteins.
dc.typearticle
dc.citation.volume30
dc.citation.issue11
dc.citation.spage2783
dc.citation.epage96
dc.citation.indexPubmed
dc.identifier.DOIhttps://doi.org/10.1007/s11274-014-1714-0


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record